Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
HQ Singapore · Asia-Pacific
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products not yet catalogued.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Dec 2024: Doctor Anywhere cut about 45 staff (around 8% of its Southeast Asia workforce), citing economic challenges; it said only duplicative roles were affected and no doctors lost their jobs.
Nov 2026: Doctor Anywhere reported a malicious cyber incident involving unauthorised third-party access to personal data, also affecting clients of subsidiary Adept Health; Singapore's PDPC is investigating. The company says clinical records were not affected. NHS DSPT status not yet checked.
No regulatory actions or clinical safety incidents involving Doctor Anywhere found in HSH's search of the last 24 months.
Jan 2026: Doctor Anywhere announced a partnership with Lumens Group to expand home-based healthcare services in Singapore. No contract disputes or terminations involving Doctor Anywhere found in HSH's search of the last 24 months.
No competitors linked yet.